Q'Apel Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
116
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Q'Apel General Information
Description
Developer of medical devices designed to help physicians overcome their challenges concerning the delivery of successful neurovascular procedures. The company's devices offer access to endovascular treatment of stroke and cerebral aneurysms, providing better trackability in navigating tortuous neurovasculature, enabling medical practitioners to improve both clinical and patient outcomes.
Contact Information
Website
www.qapelmedical.comCorporate Office
- 4245 Technology Drive
- Fremont, CA 94538
- United States
Corporate Office
- 4245 Technology Drive
- Fremont, CA 94538
- United States
Q'Apel Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Later Stage VC | 09-May-2024 | Completed | Generating Revenue | |||
| 6. Debt - General | 01-Aug-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 10-May-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 11-Feb-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 04-Feb-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | $15M | $15M | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
Q'Apel Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 11,378,838 | $0.001000 | 8% | $1.06 | $1.06 | 1x | $1.06 | 12.1% |
| Series A | 15,100,000 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 16.06% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Q'Apel Comparisons
Industry
Financing
Details
Q'Apel Competitors (37)
One of Q'Apel’s 37 competitors is Bluegrass Vascular Technologies, a Formerly VC-backed company based in San Antonio, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bluegrass Vascular Technologies | Formerly VC-backed | San Antonio, TX | ||||
| Imperative Care | Venture Capital-Backed | Campbell, CA | ||||
| Biotronik | Corporate Backed or Acquired | Berlin, Germany | ||||
| Kardium | Private Equity-Backed | Burnaby, Canada | ||||
| Cardiac Dimensions | Venture Capital-Backed | Kirkland, WA |
Q'Apel Patents
Q'Apel Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260294440-A1 | Laser cut catheters for vascular embolization | Pending | 25-Mar-2025 | ||
| WO-2026206829-A1 | Laser cut catheters for vascular embolization | Pending | 25-Mar-2025 | ||
| WO-2026169568-A1 | Flexible tip for aspiration catheters | Pending | 04-Feb-2025 | ||
| US-20260115421-A1 | Laser-cut tube catheter assembly having variable stiffness | Pending | 31-Oct-2024 | ||
| WO-2026096651-A1 | Laser-cut tube catheter assembly having variable stiffness | Pending | 31-Oct-2024 | A61M25/0013 |
Q'Apel Signals
Q'Apel Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| RC Capital (Cincinnati) | Growth/Expansion | Minority | ||
| Soleus Capital | Asset Manager | Minority | ||
| Research Corporation Technologies | Venture Capital | Minority |
Q'Apel FAQs
-
When was Q'Apel founded?
Q'Apel was founded in 2015.
-
Where is Q'Apel headquartered?
Q'Apel is headquartered in Fremont, CA.
-
What is the size of Q'Apel?
Q'Apel has 116 total employees.
-
What industry is Q'Apel in?
Q'Apel’s primary industry is Therapeutic Devices.
-
Is Q'Apel a private or public company?
Q'Apel is a Private company.
-
What is Q'Apel’s current revenue?
The current revenue for Q'Apel is .
-
How much funding has Q'Apel raised over time?
Q'Apel has raised $96.5M.
-
Who are Q'Apel’s investors?
RC Capital (Cincinnati), Soleus Capital, and Research Corporation Technologies have invested in Q'Apel.
-
Who are Q'Apel’s competitors?
Bluegrass Vascular Technologies, Imperative Care, Biotronik, Kardium, and Cardiac Dimensions are some of the 37 competitors of Q'Apel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process